Semaglutide
GLP-1 receptor agonist analog
A long-acting GLP-1 receptor agonist analog (31 amino acids, fatty-acid-acylated for extended half-life), studied extensively in metabolic research literature examining glucose homeostasis, appetite regulation, and — increasingly — cardiovascular and cognitive research endpoints.
What researchers are studying Semaglutide for.
GLP-1 Receptor Agonism
Cardiovascular Research
Cognitive Research
31-amino-acid, fatty-acid-acylated GLP-1 analog — full sequence via certificate of analysis
Concentration and unit math, worked out.
Worked example for a 10mg vial reconstituted with 3mL of bacteriostatic water, drawn on a U-100 insulin syringe. Use the calculator below for any other vial size or water volume.
| UNITS DRAWN | VOLUME | DELIVERS |
|---|---|---|
| 5 units | 0.05 mL | 167 mcg |
| 10 units | 0.10 mL | 333 mcg |
| 20 units | 0.20 mL | 667 mcg |
| 30 units | 0.30 mL | 1000 mcg |
| 50 units | 0.50 mL | 1667 mcg |
Run your own numbers.
Pre-filled with a 30-day starting point — one vial, dosed once daily for 30 days. Adjust any field to match your own protocol.
RESULTS
Educational reference tool only — not medical advice. Reconstitution and dosing decisions for any research protocol should be reviewed with a qualified professional. Figures assume uniform mixing and standard syringe calibration; always verify against your own protocol.